Delivery Order SPE2DB22D1103-SPE2DB25FTEH2

Award Date 1/16/25
Potential Completion Date 1/17/25
Potential Value $3.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of STELARA 45 MG/0.5 ML SYRINGE 0.5ML, a specialty medication. The contract has a ceiling value of $3,684.96 and runs through March 27, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of STELARA 45 MG/0.5 ML SYRINGE 0.5ML. The contract has a firm fixed price of $6,390.54 and a period of performance through April 2, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which provides a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of STELARA 45 MG/0.5 ML SYRINGE 0.5ML, a specialty medication, with a ceiling value of $15,917.42 and a performance period through May 12, 2023. The contract is a firm fixed-price delivery order, which is a type of Indefinite Delivery Contract (IDC) that the...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of STELARA 45 MG/0.5 ML VIAL 0.5ML. The contract has a ceiling value of $4,729.11 and runs through December 26, 2024. It is a Firm Fixed Price contract, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 through November 2026,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of STELARA 45 MG/0.5 ML SYRINGE 0.5ML, a pharmaceutical product, with a ceiling value of $5,178.53 and a completion date of October 16, 2023. The contract is a Firm Fixed Price type and does not have a set-aside designation, indicating open competition. Amerisourcebergen also holds...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $15,060.83, is for the supply of STELARA 90 MG/ML syringes. The contract is a firm fixed-price arrangement with a completion date of January 23, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,530.93, is for the supply of STELARA 45 MG/0.5 ML SYRINGE 0.5ML medical products. The contract is a Firm Fixed Price arrangement and has an ultimate completion date of February 18, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Stelara 45 mg/0.5 ml syringes. The contract has a ceiling value of $28,814.13 and a period of performance through April 29, 2025. It is a firm fixed-price contract, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of STELARA 45 MG/0.5 ML SYRINGE 0.5ML. The contract has a ceiling value of $5,448.15 and a period of performance through January 6, 2025. This is a firm fixed-price contract with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of STELARA 45 MG/0.5 ML SYRINGE 0.5ML, a specialty medication, with a ceiling value of $7,369.92 and a period of performance through April 1, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
  • SPE2DB22D1103
    Indefinite Delivery Contract
  • SPE2DB22D1103-SPE2DB25FTEH2
    Delivery Order

This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of STELARA 45 MG/0.5 ML SYRINGE 0.5ML. The contract has a ceiling value of $3,897.18 and a performance period through January 17, 2025. It is a Firm Fixed Price contract with no set-aside designation, indicating open competition. Amerisourcebergen also holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 4/21/25, 3:34 AM